Left Out in the Cold: Moving beyond Hormonal Therapy for the Treatment of Immunologically Cold Prostate Cancer with CAR T Cell Immunotherapies

Scientists discuss the innovative and rationally designed strategies under investigation to improve the clinical translation of cellular immunotherapy in prostate cancer and maximize therapeutic outcomes for these patients.